The GPS Plan: GLP-1s, Protein, and Strength Training for Sustainable Metabolic Health One of my favorite moments in our conversation was when Dr
doi: 10.3389/fmed.2023.1124275 Received 14 December 2022 Accepted 27 February 2023 Published 22 March 2023 Volume 10 - 2023 Edited by Ana Sandoval-Rodriguez, University of Guadalajara, Mexico Reviewed by Angelo Armandi, University of Turin, Italy
Given the progressive nature of DKD, early disease management prioritizes stringent targets, aligning with KDIGO guidelines that recommend a systolic blood pressure goal of 30 mg/g) despite a maximum tolerated dose of RAS inhibitor (58)
So Ozempic is a much less frequent treatment in comparison
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates key variants in the GLP1R gene (rs6923761) and related metabolic pathways that may help provide context for individual side effect timing and severity